focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Crystal Amber withdraws requisition of Allied Minds

11 Dec 2019 15:13

Crystal Amber Fund Limited - Crystal Amber withdraws requisition of Allied Minds

Crystal Amber Fund Limited - Crystal Amber withdraws requisition of Allied Minds

PR Newswire

London, December 11

11 December 2019

CRYSTAL AMBER FUND LIMITED

(“Crystal Amber Fund” or the “Fund”)

Crystal Amber Fund withdraws requisition of General Meeting of Allied Minds plc

Crystal Amber Fund, the activist investment fund, notes the announcement made today by the Board of Allied Minds plc (“Allied Minds”) in response to the Fund’s general meeting requisition announced on 21 November 2019. In light of Allied Minds’ appointment to its board of Mark Lerdal, the director candidate proposed by the Fund (who has directly relevant experience of realising shareholder value from a comparable US-based, UK-listed company), and the other announced changes to the Allied Minds board and to executive compensation, the Fund has formally withdrawn the requisition notice.

Actions such as the announced board changes and the focus on maximising cash returns to shareholders – not least from the recent sale of Allied Minds’ stake in HawkEye 360 – demonstrate the value of Crystal Amber Fund’s activist investment approach.

Richard Bernstein, investment adviser to Crystal Amber Fund, said: “We have always attempted to engage positively in a private manner with our investee companies in an effort to effect change in the interests of all shareholders. This is one of a small number of cases where we have felt obliged to take public action to ensure that shareholder interests are being properly considered. We are pleased that the Board of Allied Minds has engaged with us and the outcome of this process is an acknowledgment that Allied Minds can do more to maximise the realisation of shareholder value. We are also encouraged about the progress we believe can now be made in this regard.

For further enquiries please contact:

Crystal Amber Fund Limited
Christopher Waldron (Chairman)Tel: 01481 742 742
Allenby Capital Limited - Nominated Adviser
David Worlidge/Liz KirchnerTel: 020 3328 5656
Winterflood Investment Trusts - Broker
Joe Winkley/Neil LangfordTel: 020 3100 0160
Crystal Amber Advisers (UK) LLP - Investment Adviser
Richard BernsteinTel: 020 7478 9080
Date   Source Headline
31st Jan 20173:55 pmRNSTotal Voting Rights
30th Jan 201712:02 pmRNSPrice Monitoring Extension
3rd Jan 20172:48 pmRNSHolding(s) in Company
3rd Jan 20172:11 pmRNSTotal Voting Rights
13th Dec 20167:00 amRNSFormation of Signature Medical, Inc.
9th Dec 20165:04 pmRNSHolding(s) in Company
7th Dec 20164:34 pmRNSHolding(s) in Company
6th Dec 20165:05 pmRNSHolding(s) in Company
6th Dec 20165:04 pmRNSHolding(s) in Company
2nd Dec 20167:00 amRNSResults of equity placing
1st Dec 20164:50 pmRNSProposed Equity Placing
23rd Nov 20167:00 amRNSHawkEye 360 Raises $11m in Series A Financing
21st Nov 20167:00 amRNSFormation of Vatic Materials, Inc.
18th Nov 20163:15 pmRNSBlock Listing Six Monthly Return
11th Nov 20165:17 pmRNSHolding(s) in Company
24th Oct 20167:00 amRNSPrecision Biopsy Raises $5.0 Million
17th Oct 201612:07 pmRNSSecond Price Monitoring Extn
17th Oct 201612:02 pmRNSPrice Monitoring Extension
29th Sep 20167:00 amRNSAllied Minds & GE Ventures Form Strategic Alliance
8th Sep 201612:02 pmRNSPrice Monitoring Extension
31st Aug 20165:11 pmRNSTotal Voting Rights
25th Aug 20167:00 amRNSHalf-year Report
22nd Aug 20167:00 amRNSAllied Minds Secures $20m Debt Facility from SVB
22nd Aug 20167:00 amRNSAllied Minds' Subsidiary ABLS II Raises $15m
1st Aug 20167:00 amRNSSciFluor Enters Clinical Trial Stage
29th Jul 201610:30 amRNSTotal Voting Rights
13th Jul 201610:02 amRNSDirector/PDMR Shareholding
13th Jul 201610:01 amRNSDirector/PDMR Shareholding
13th Jul 201610:01 amRNSDirector/PDMR Shareholding
13th Jul 201610:00 amRNSDirector/PDMR Shareholding
7th Jul 20167:00 amRNSLong Term Incentive Plan - Listing Application
30th Jun 20167:00 amRNSTotal Voting Rights
22nd Jun 20164:41 pmRNSSecond Price Monitoring Extn
22nd Jun 20164:35 pmRNSPrice Monitoring Extension
14th Jun 20162:38 pmRNSDirector/PDMR Shareholding
13th Jun 20165:18 pmRNSDirector/PDMR Shareholding
31st May 20164:44 pmRNSBlocklisting Six Monthly Return
26th May 20165:23 pmRNSResult of AGM
26th May 20167:00 amRNSAGM Statement
25th May 20167:00 amRNSABLS II Completes Drug Feasibility Programme
13th May 20167:00 amRNSDirector/PDMR Shareholding
10th May 20164:30 pmRNSLong Term Incentive Plan
28th Apr 201612:33 pmRNSHolding(s) in Company
26th Apr 20167:00 amRNSAllied Minds Raises $80m for ABLS Capital
25th Apr 20167:00 amRNSAnnual Financial Report
19th Apr 20167:00 amRNSAppointment of Joint Broker
16th Mar 20167:00 amRNSABLS agrees license with NYU
10th Feb 20164:40 pmRNSSecond Price Monitoring Extn
10th Feb 20164:36 pmRNSPrice Monitoring Extension
9th Feb 20164:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.